Secondary Logo

H-105 Reflections on the impact of nucleotide antiviral drugs

Martin, John, PhD

JAIDS Journal of Acquired Immune Deficiency Syndromes: April 2018 - Volume 77 - Issue - p 47
doi: 10.1097/01.qai.0000532626.00464.29
Abstracts: PDF Only
Free

Antiviral nucleotide prodrugs have benefitted patients suffering from HIV and viral hepatitis, providing for the possibility to live longer, healthier lives. In addition, tenofovir has allowed for pre-exposure prophylaxis to prevent HIV infection. This is an example of the pioneering work of Salim and Quarraisha Karim.

Gilead Sciences

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.